PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Association of British Healthcare Industries

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ABHI Welcomes EU Decision on Advanced Therapies - The Association of British Healthcare Industries (ABHI) welcomes EU decision to adopt the Advanced Therapy Medicinal Products Regulation, harmonising the use of human tissue engineered products in the EU
ABHI Welcomes EU Decision on Advanced Therapies

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/06/05 - The Association of British Healthcare Industries (ABHI) welcomes EU decision to adopt the Advanced Therapy Medicinal Products Regulation, harmonising the use of human tissue engineered products in the EU.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

On 31 May 2007 EU Health Ministers adopted the Advanced Therapy Medicinal Products (ATMP) Regulation, accepting the compromise package adopted on 25 April by the European Parliament.

The new Regulation will provide the long-awaited harmonised framework for the evaluation, authorisation and marketing of human tissue-engineered products in the European Union. Human tissue-engineering and the use of "smart" biomaterials that promote self-repair of damaged tissues offer tremendous promise for improved patient treatment, faster recovery, improved prognosis and a more biologically favourable situation where the body can be stimulated to heal itself.

ABHI Technical and Regulatory Director Mike Kreuzer said:
“ABHI welcomes the recent EU Council vote on the Advanced Therapy Regulation which paves the way for improved treatment using Regenerative medicine products which are already changing today's medical practice. Furthermore the ABHI (abhi.org.uk) supports the exclusion of tissue engineered products containing or made exclusively from non-viable human or animal cells which do not act as pharmaceuticals from the scope of the ATMP Regulation. Such products could well be covered by legislation based on the principles of the Medical Devices Directives which allow research and innovation to be encouraged and sustained whilst at the same time ensuring a high level of patient safety and equitable access to treatment.”

In its 2007 work programme, the European Commission has already envisaged the necessary steps to build a regulatory framework, based on the priciples of the MDD, for products excluded from the ATMP Regulation . As an active member of the European trade association Eucomed the ABHI will continue to work with the European Commission, the European Medicines Evaluation Agency (EMEA) and other stakeholders in order to develop the most appropriate regulatory regime.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Association of British Healthcare Industries

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


ABHI Welcomes EU Decision on Advanced Therapies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Guy Rowland - ABHI.org.uk 
+44(0)20 7960 4360 guy.rowland[.]abhi.org.uk
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Association of British Healthcare Industries securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Association of British Healthcare Industries / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)